Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for July 2010
July 1, 2010
- Compugen Discovered Protein Shown to Abolish Recurring Relapses in Multiple Sclerosis Animal Model
- Phase III Study Shows Novartis Drug Afinitor More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
- Chelsea Therapeutics Reports Positive Interim Analysis of Phase II Trial of Droxidopa in Fibromyalgia
- Eiger BioPharmaceuticals Announces New HCV Synergy Data
- Stem-Cell Therapy May Provide New Approach To Fight Infection
- Stanford Study Shows Key Enzyme In Fetal Heart Development Also Involved In Adult Heart Disease
- New Insights Into Link Between Anti-Cholesterol Statin Drugs And Depression
- RNA Therapeutics Expert Joins Kylin's Scientific Advisory Board
- NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
- Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
- Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
- FASEB Welcomes New President, William T. Talman, M.D.
July 2, 2010
- Patients With Treatment-Resistant Chronic Leukemia Respond Positively to Stem Cell Transplants
- Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza
- Second Phase III Study Showed Avastin-Containing Regimen Helped Women With Ovarian Cancer Live Longer Without Their Disease Getting Worse
- Dr Huw Jones appointed CEO
- Brain atrophy responsible for depression in people battling multiple sclerosis
- Inspire Announces Management Structure Changes
- Biodel Abstracts to be Presented at 46th Annual Meeting of European Association for the Study of Diabetes
- Experimental nonsteroidal treatment of asthma shows promise
- Genetic regulator opens new avenues to AIDS, immune system research
- Stroke complications may subtract additional two years of healthy life
- Hodgkin Lymphoma Patients With Cardiovascular Disease Have Increased Risk of Post-Treatment Cardiac Hospitalization
- Cellular and molecular events that restrict HIV transmission identified
- Work-life balance: Brain stem cells need their rest, too
- Historic HIV Vaccine Trial Involving GeoVax Vaccine Spotlighted in The Georgia Voice and The Body
July 6, 2010
- EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients
- Rexahn Pharmaceuticals Announces Formation of Scientific Advisory Board in Major Depressive Disorder
- Combination of Imprime PGG and Erbitux Doubles the Therapeutic Response in Colorectal Cancer Patients in Phase Ib/IIa Trial
- Genmab Announces Interim Results of Ofatumumab Phase II Study in Multiple Sclerosis
- AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
- Study Shows Once-Daily Morning Retinoid Acne Regimen Simplifies Treatment Without Sacrificing Results
- Eliseo O. Salinas, MD, MSc Joins Elan as Executive Vice President and Chief Medical Officer
July 7, 2010
- Probiodrug Further Expands Scientific Advisory Board by Appointing Prof Dr Dr hc Christian Haass
- GlaxoSmithKline and XenoPort Report Top-Line Phase 2b Results for GSK1838262/XP13512 as a Prophylactic Treatment for Migraine Headache
- Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
- Dr. Michael Tomlinson Joins Wax-it Histology Services as Lead Pathologist
- Illumina Names Gerald Möller to Board of Directors
- Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
- BioTime Announces Passing of Board Director Dr. Robert N. Butler
- Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas
- K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
July 8, 2010
- NKTR-102 Demonstrates Superior Activity to Irinotecan in Nonclinical Studies Presented at ESMO 12th World Congress on Gastrointestinal Cancer
- Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
- Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
- Novel UV protecting drug delivered by the picogram
- ImmunoCellular Appoints Two New Members to Scientific Advisory Board
- Ingen Biosciences appoints Research & Development Director
July 9, 2010
- Positive Results from Phase II VTE Prophylaxis Study with TB-402 (Anti-Factor VIII) Presented at the 21st International Congress on Thrombosis in Milan, Italy
- QTI571 in severe PAH publication in Am J Respir Crit Care Med
- New Data Demonstrate Zyclara Imiquimod 3.75% Superior to Placebo for Treatment of External Genital Warts (EGW)
July 12, 2010
- Data on VIVUS' Qnexa to be Presented at International Congress on Obesity
- ReNeuron presents new data showing how its stem cells work to repair brain damage
- Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress
- AlphaRx Announces the Podium Presentation of GAI-122 Injectable Nanoemulsion for Neuroprotection at Controlled Release Society Annual Meeting
- Medivir Announces Phase 2b 24-week Interim Results of TMC435 in Treatment-naïve Patients Chronically Infected with Genotype-1 Hepatitis C Virus
- Bitop AG Reports That Ectoin Reduces Symptoms of Acute Allergic Rhinitis
- Novelos Therapeutics Announces Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at Sylvester Comprehensive Cancer Center, at the University of Miami
- New Research Uncovers Why Many With Lupus Are Resistant to Traditional Treatments
- Edoxaban Demonstrates Superior Efficacy Compared With Enoxaparin Sodium In Preventing Vte After Total Knee Replacement
- Caldolor (Ibuprofen) Injection Shown to Significantly Reduce Fever in Malaria Patients in Newly Published Clinical Trial
- Mayo Clinic Study Finds Apathy and Depression Predict Progression from Mild Cognitive Impairment to Dementia
- Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress
- AmpliMed Reports Results from AMP-019; A Randomized Double Blind Trial of Gemcitabine/Placebo vs. Gemcitabine/Amplimexon in Advanced Pancreatic Cancer
- SurModics Showcases Drug Delivery Technology at The 37th Annual Meeting and Exposition of the Controlled Release Society
- Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
July 13, 2010
- MAP Pharmaceuticals Announces Results from Levadex Pharmacokinetics Trial in Smokers
- Clinuvel Pharmaceuticals Limited (ASX:CUV) Successful Drug Trial Results For Light Intolerant Shadow Jumpers
- EntreMed's ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models
- New Study Reveals Proprietary Saw Palmetto Extract (SPET-085) Supplement Can Effectively Inhibit the Enzyme Linked to Benign Prostatic Hyperplasia (BPH)
- EDP Announces Single Injection of New Insulin Maintains Tight Glucose Control for 140 Days
- Addex drug candidate effective in osteoarthritis pain model
- Real-World Experience Confirms Low Inhibitor Rate Established in ADVATE Controlled Clinical Studies for Hemophilia Patients
- Metabolon Study Suggests Mechanism of Ethylene Glycol Monomethyl Ether-Induced Toxicity
- Four New Research Studies Describe Experimental Immunotherapies for Alzheimer's
- Biodel Reports Progress with Development of Glucose-Regulated 'Smart' Basal Insulin
- An Obesity Gene, Known as FTO, Also May Increase Risk of Alzheimer's Disease and Dementia
July 14, 2010
- QR Pharma's Posiphen Was Shown in a Clinical Mechanism of Action Study to Enter the Brain and to Inhibit Amyloid Precursor Protein
- EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's Disease
- Eden Biodesign Assists Momotaro-Gene, Inc. to Commence Human Clinical Trials Less Than 12 Months After Being Engaged to Produce a Recombinant Adenovirus Vector from a New Cell Line
July 15, 2010
- New England Journal of Medicine Publishes Results of Two-Year BLOOM Trial Showing Lorcaserin Caused Significant Weight Loss and Improved Maintenance of Weight Loss
- Noscira Presents Results of Phase IIa Clinical Trial with Nypta (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)
- PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
- ARUP Laboratories to Make Strong Showing at American Association for Clinical Chemistry (AACC) 2010 Annual Meeting & Clinical Lab Expo in Anaheim on July 28
- R-Tech Ueno Completes Phase II Clinical Study on Ophthalmic Solution UF-021 (Product Name Ocuseva ) on Retinitis Pigmentosa (2)
- ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina
- After 40 Years, NIH-Supported Researchers Identify Possible New Treatment For Severe Vasculitis
July 16, 2010
- Steroids Help Preserve Kidney Function in Type of Kidney Disease
- Epizyme Scientists Detail Epigenetic Approaches to Cancer Therapy in Drug Discovery Today: Therapeutic Strategies and Current Opinion in Chemical Biology
- New Discovery Brings Hope to Treatment of Incurable Blood Cancer
- New Research Advances from the Alzheimer's Association International Conference on Alzheimer's Disease 2010
- Cubist Announces Objectives Met in Phase 2 Safety Study of CUBICIN in Prosthetic Joint Infections
- New Research Presented at Alzheimer's Association International Conference on Alzheimer's Disease Indicates Alzheimer's Disease May Lead to Increased Comorbid Conditions and Economic Burden
- Alzheimer's Disease May Increase Risk of Anemia and Seizures
July 19, 2010
- Nanoviricides Anti-Ebola Results Presented at Annual Meeting of the American Society for Virology by USAMRIID Scientist
- Prana's Research Presented at International Conference on Alzheimer's Disease on July 14
- Abbott's Progress Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
- Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice
- Tobira's Next-Generation Once-Daily CCR5/CCR2 Antagonist Demonstrates Potent CCR2 Inhibition, Antiviral Activity, Safety and Tolerability in Treatment-Experienced Patients With HIV
- Argos Therapeutics' Arcelis HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study
- Immunacia's ViroStatics Reports Phase II Data on VS411, an AV-HALT for Treating HIV/AIDS, During the XVIII International AIDS Conference
- Phase II Data from FIT Biotech's HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
- Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naïve Individuals
- New Scientific Evidence Links Autism to Vaccines and Mercury
- World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients
- Researchers Report in Neuroscience that TB4 Improves Neurological Function after Stroke
- Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
- Vaccine Reduces Pneumonia and Complications in Infants, Study Says
- ArmaGen Re-engineers Erythropoietin for Brain Penetration
- HIV/AIDS Treatment Curbs Spread of HIV Among Drugs Users, According to NIH Supported Study
July 20, 2010
- Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis
- Microbicide Trial Lifts Hope for Women's HIV Prevention
- Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN)
- Statement From USAID Administrator Rajiv Shah in Response to Today's Historic Progress in Preventing HIV Infection in Women
July 21, 2010
July 22, 2010
- CytRx's Tamibarotene Eradicates Cancer in Advanced Acute Promyelocytic Leukemia After Failure of Other Therapies
- TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective
- Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference
July 23, 2010
- Study shows once-daily, extended-release formulation of nevirapine was not inferior to twice-daily Viramune in treatment-naïve HIV-1 infected patients
- NIH-Funded Study Finds Early Haart During TB Treatment Boosts Survival Rate In People Co-Infected With HIV And TB
- Stopping Anemia Drug May be Wiser than Reducing Dose to Normalize Hemoglobin Levels
- XenoPort Announces Presentation of Preclinical Data for Acamprosate Prodrug at Fragile X Syndrome Conference
- Horizon Pharma, Inc. Announces Results of Phase 3 Study of Lodotra Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
- Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
July 26, 2010
- Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data From Phase 2b Study
- Asuragen and Collaborators Report Results Using PCR-only Technologies for the Comprehensive Molecular Assessment of the Fragile X Gene
- Seaside Therapeutics Reports Data from Randomized, Placebo-Controlled Phase 2 Study in Fragile X Syndrome
- QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo IR Development and Registration
- Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro
- Can-Fite Drug Candidate CF102 Significantly Decreased Viral Load of HCV in 3 Patients with Liver Cancer
- Gamma-Tocotrienol Kills Prostate Cancer Stem Cells
- Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and Demonstrate Significant Therapeutic Benefit in Animal Models
- New Compound Improves Obesity-Related Health Complications in NIH-Led Study
July 27, 2010
- Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial
- Peer-Reviewed Journal Publishes Findings by Viral Genetics' Lead Scientist
- Results from Two Multi-Site Collaborative Studies Highlight the Value of 454 Sequencing Systems for Genotyping Applications
- Treatments for Blocked Carotid Arteries Vary by U.S. Region
- Our children aren't sleeping and we're medicating them
- Researchers uncover biological rationale for why intensive lupus treatment works
- Antares Pharma Announces Positive Top Line Results From Its Pivotal Phase 3 Study of Anturol Gel for the Treatment of Overactive Bladder
- Synta Announces STA-9090 Results Published in Journal ?Blood? Demonstrating Potent In Vitro and In Vivo Activity in AML
July 28, 2010
- Allos Therapeutics Announces Topline Results from Phase 2b Study of Folotyn in Patients with Advanced Non-Small Cell Lung Cancer
- Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology
- Trophos publishes the identification and characterization of the novel cardioprotective compound, TRO40303
- Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir
- Study Showed the Clinically Significant Therapeutic Benefit of Neupro (rotigotine transdermal system) in the Treatment of Restless Legs Syndrome
- Limerick BioPharma Announces Positive Phase 1b Data for LIM-0705 in Preventing Toxicities Associated with the Transplant Drug, Tacrolimus
- Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
- Advaxis Phase I Survival Update
July 29, 2010
- Nymox Reports Safety Monitoring Committee Findings For Pivotal Phase 3 NX-1207 Trials
- ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
- Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
- CytRx's Tamibarotene Eradicates Former NBA Player's Aggressive, Advanced-Stage Leukemia
- Data on VIVUS' Qnexa To Be Presented at the National Medical Association Annual Assembly
- Generex Provides Positive Update on Generex Oral-lyn Pivotal Phase III Trial
- Chimerix CMX157 Shows Potential to Treat Multi-Drug Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir
- Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
- Study Analysis Identifies Potential Biomarkers of Velcade (Bortezomib) Activity in Patients with Relapsed Mantle Cell Lymphoma
- New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study
July 30, 2010
- Basilea Pharmaceutica AG (CH) - Data on Basilea's Toctino in Daily Medical Practice in Germany Presented at Dermatology Congress
- Study Results Show That Oral Contraceptives/Hormone Replacement Therapy May Protect Against Brain Aneurysms
- Orexigen Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
